Literature DB >> 24187062

μLC-ICP-MS determinations of unexposed UK urinary arsenic speciation reference values.

Elizabeth Leese1, Jackie Morton, Emma Tan, Philip H E Gardiner, Vikki A Carolan.   

Abstract

This study provides background levels for five arsenic species in urine, based on urinary data obtained from 95 nonoccupationally exposed volunteers based in the UK. Using a novel, sensitive, robust and reliable speciation methodology, five species of arsenic (arsenobetaine [AB], arsenite [As(3+)], arsenate [As(5+)], monomethylarsonic acid [MMA(5+)] and dimethylarsinic acid [DMA(5+)]) were determined in urine samples collected from 95 adults. The analytical instrumentation used to analyze the urine samples was a hyphenated micro liquid chromatography (μLC) system coupled to an inductively coupled plasma mass spectrometry (ICP-MS). Separation was achieved using an anion exchange micro-sized column. The results presented give the 95th percentile of concentrations, both uncorrected for creatinine (µg/L) and creatinine corrected (µmol/mol) in urine for the 95 volunteers. Statistical analysis was performed on the dataset using a Bayesian model to determine and quantify effects of gender, smoking and diet. The statistical results show that the consumption of fish, shellfish and red wine has a significant elevating effect on AB, DMA and MMA urinary concentrations; however, no significant effect was observed for smoking. The regression model results indicate that creatinine correction was effective for arsenic species As(3+), MMA, DMA and AB. The background levels established here can be used as reference values to help aid interpretation of arsenic speciation results and better assess exposure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24187062      PMCID: PMC4481610          DOI: 10.1093/jat/bkt090

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  15 in total

1.  Biological monitoring of occupational exposure to inorganic arsenic.

Authors:  P Apostoli; D Bartoli; L Alessio; J P Buchet
Journal:  Occup Environ Med       Date:  1999-12       Impact factor: 4.402

2.  Creatinine adjustment of biological monitoring results.

Authors:  J Cocker; H J Mason; N D Warren; R J Cotton
Journal:  Occup Med (Lond)       Date:  2011-08       Impact factor: 1.611

3.  Distribution and fate of inorganic and organic arsenic species in landfill leachates and biogases.

Authors:  P Pinel-Raffaitin; I Le Hecho; D Amouroux; M Potin-Gautier
Journal:  Environ Sci Technol       Date:  2007-07-01       Impact factor: 9.028

4.  Korea National Survey for Environmental Pollutants in the Human Body 2008: heavy metals in the blood or urine of the Korean population.

Authors:  Jong Wha Lee; Chae Kwan Lee; Chan Seok Moon; In Ja Choi; Kee Jae Lee; Seung-Muk Yi; Bong-Ki Jang; Byoung Jun Yoon; Dae Seon Kim; Domyung Peak; Donggeun Sul; Eunha Oh; Hosub Im; Hee Sook Kang; Jeounghee Kim; Jong-Tae Lee; Kisok Kim; Kyung Lyoul Park; Ryoungme Ahn; Seok Hwan Park; Seong Cheon Kim; Choong-Hee Park; Jin Heon Lee
Journal:  Int J Hyg Environ Health       Date:  2012-02-16       Impact factor: 5.840

5.  Arsenic speciation in clinical samples: urine analysis using fast micro-liquid chromatography ICP-MS.

Authors:  Jackie Morton; Elizabeth Leese
Journal:  Anal Bioanal Chem       Date:  2010-09-24       Impact factor: 4.142

6.  Arsenic species excretion after controlled seafood consumption.

Authors:  Regine Heinrich-Ramm; Susanne Mindt-Prüfert; Dieter Szadkowski
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-10-05       Impact factor: 3.205

7.  Analytical artefacts in the speciation of arsenic in clinical samples.

Authors:  Zdenka Slejkovec; Ingrid Falnoga; Walter Goessler; Johannes T van Elteren; Reingard Raml; Helena Podgornik; Peter Cernelc
Journal:  Anal Chim Acta       Date:  2007-11-23       Impact factor: 6.558

8.  Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.

Authors:  Yung-Kai Huang; Ya-Li Huang; Yu-Mei Hsueh; Mo-Hsiung Yang; Meei-Maan Wu; Shu-Yuan Chen; Ling-I Hsu; Chien-Jen Chen
Journal:  Cancer Causes Control       Date:  2008-03-20       Impact factor: 2.506

9.  Fast determination of arsenic species and total arsenic in urine by HPLC-ICP-MS: concentration ranges for unexposed german inhabitants and clinical case studies.

Authors:  Peter Heitland; Helmut D Köster
Journal:  J Anal Toxicol       Date:  2008-05       Impact factor: 3.367

10.  Urinary arsenic levels in the French adult population: the French National Nutrition and Health Study, 2006-2007.

Authors:  Abdessattar Saoudi; Abdelkrim Zeghnoun; Marie-Laure Bidondo; Robert Garnier; Vincent Cirimele; Renaud Persoons; Nadine Fréry
Journal:  Sci Total Environ       Date:  2012-07-13       Impact factor: 7.963

View more
  4 in total

1.  Urinary arsenic profiles reveal exposures to inorganic arsenic from private drinking water supplies in Cornwall, UK.

Authors:  D R S Middleton; M J Watts; E M Hamilton; E L Ander; R M Close; K S Exley; H Crabbe; G S Leonardi; T Fletcher; D A Polya
Journal:  Sci Rep       Date:  2016-05-09       Impact factor: 4.379

Review 2.  Positive Association of Cardiovascular Disease (CVD) with Chronic Exposure to Drinking Water Arsenic (As) at Concentrations below the WHO Provisional Guideline Value: A Systematic Review and Meta-Analysis.

Authors:  Lingqian Xu; Debapriya Mondal; David A Polya
Journal:  Int J Environ Res Public Health       Date:  2020-04-07       Impact factor: 3.390

3.  Assessment of museum staff exposure to arsenic while handling contaminated exhibits by urinalysis of arsenic species.

Authors:  Amanda Mithander; Thomas Göen; Gitte Felding; Peter Jacobsen
Journal:  J Occup Med Toxicol       Date:  2017-08-25       Impact factor: 2.646

4.  The Investigation of Unexpected Arsenic Compounds Observed in Routine Biological Monitoring Urinary Speciation Analysis.

Authors:  Elizabeth Leese; Malcolm Clench; Jackie Morton; Philip H E Gardiner; Vikki A Carolan
Journal:  Toxics       Date:  2017-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.